Colgate-Palmolive Company (NYSE:CL)‘s stock had its “hold” rating restated by equities research analysts at Deutsche Bank AG in a report issued on Monday. They presently have a $75.00 target price on the stock. Deutsche Bank AG’s price target suggests a potential upside of 4.38% from the company’s current price.

A number of other analysts also recently issued reports on the company. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 3rd. Jefferies Group LLC reissued a “hold” rating and set a $76.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, May 17th. Bank of America Corporation raised their price objective on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. Vetr downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price objective for the company. in a research report on Wednesday, May 17th. Finally, Royal Bank Of Canada reissued a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research report on Monday, April 24th. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and three have given a buy rating to the company’s stock. Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $75.83.

Shares of Colgate-Palmolive (NYSE:CL) traded down 1.94% during mid-day trading on Monday, hitting $71.85. 4,662,283 shares of the stock were exchanged. The stock has a market cap of $63.29 billion, a price-to-earnings ratio of 26.70 and a beta of 0.81. The company has a 50-day moving average price of $74.80 and a 200-day moving average price of $72.20. Colgate-Palmolive has a 12 month low of $63.43 and a 12 month high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. The firm had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company’s quarterly revenue was down .5% on a year-over-year basis. During the same period last year, the company earned $0.70 EPS. Equities analysts expect that Colgate-Palmolive will post $2.92 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This report was originally published by Daily Political and is owned by of Daily Political. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.dailypolitical.com/2017/07/24/colgate-palmolive-company-nysecl-earns-hold-rating-from-deutsche-bank-ag.html.

In other news, Director Richard J. Kogan sold 8,000 shares of Colgate-Palmolive stock in a transaction dated Monday, May 8th. The stock was sold at an average price of $71.92, for a total value of $575,360.00. Following the completion of the transaction, the director now owns 73,065 shares in the company, valued at approximately $5,254,834.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $75.67, for a total value of $290,043.11. Following the completion of the transaction, the insider now owns 53,022 shares of the company’s stock, valued at approximately $4,012,174.74. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 29,666 shares of company stock valued at $2,144,371. 1.02% of the stock is currently owned by corporate insiders.

Several institutional investors have recently made changes to their positions in the stock. Blue Chip Partners Inc. boosted its position in shares of Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock valued at $132,000 after buying an additional 8 shares during the last quarter. Alpha Windward LLC boosted its position in shares of Colgate-Palmolive by 0.6% in the first quarter. Alpha Windward LLC now owns 2,829 shares of the company’s stock valued at $207,000 after buying an additional 18 shares during the last quarter. Cornerstone Financial Partners LLC boosted its position in shares of Colgate-Palmolive by 0.5% in the second quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock valued at $282,000 after buying an additional 19 shares during the last quarter. Northstar Group Inc. boosted its position in shares of Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock valued at $356,000 after buying an additional 20 shares during the last quarter. Finally, M Holdings Securities Inc. boosted its position in shares of Colgate-Palmolive by 0.4% in the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock valued at $393,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 73.57% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.